These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 19996923

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
    Shi W, Gao H, Xie L, Wang S.
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
    Olariu R, Denoyelle J, Leclère FM, Dzhonova DV, Gajanayake T, Banz Y, Hayoz M, Constantinescu M, Rieben R, Vögelin E, Taddeo A.
    J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
    [Abstract] [Full Text] [Related]

  • 46. A local drug delivery system prolongs graft survival by dampening T cell infiltration and neutrophil extracellular trap formation in vascularized composite allografts.
    Arenas Hoyos I, Helmer A, Yerly A, Lese I, Hirsiger S, Zhang L, Casoni D, Garcia L, Petrucci M, Hammer SE, Duckova T, Banz Y, Montani M, Constantinescu M, Vögelin E, Bordon G, Aleandri S, Prost JC, Taddeo A, Luciani P, Rieben R, Sorvillo N, Olariu R.
    Front Immunol; 2024 Oct; 15():1387945. PubMed ID: 38887281
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Immunological issues in clinical composite tissue allotransplantation: where do we stand today?
    Morelon E, Kanitakis J, Petruzzo P.
    Transplantation; 2012 May 15; 93(9):855-9. PubMed ID: 22538449
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
    Schrepfer S, Deuse T, Koch-Nolte F, Krieger T, Haddad M, Schäfer H, Pelletier MP, Robbins RC, Reichenspurner H.
    J Heart Lung Transplant; 2007 Jan 15; 26(1):70-7. PubMed ID: 17234520
    [Abstract] [Full Text] [Related]

  • 52. Sensorimotor recovery after partial facial (mystacial pad) transplantation in rats.
    Landin L, Cavadas PC, Gonzalez E, Caballero-Hidalgo A, Rodriguez-Perez JC.
    Ann Plast Surg; 2009 Oct 15; 63(4):428-35. PubMed ID: 19745713
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts.
    Suzuki J, Koga N, Kosuge H, Ogawa M, Haraguchi G, Maejima Y, Saiki H, Isobe M.
    Transplantation; 2007 Apr 27; 83(8):1093-7. PubMed ID: 17452900
    [Abstract] [Full Text] [Related]

  • 55. Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study.
    Buadi FK, Heyman MR, Gocke CD, Rapoport AP, Hakimian R, Bartlett ST, Sarkodee-Adoo C.
    Am J Hematol; 2007 Mar 27; 82(3):208-14. PubMed ID: 17022049
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Pharmacogenetic vs. concentration-controlled optimization of tacrolimus dosing in renal allograft recipients.
    Kuypers DR.
    Clin Pharmacol Ther; 2010 Nov 27; 88(5):595-6; author reply 597. PubMed ID: 20664539
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.